TY - JOUR
T1 - Sphingosine-1-phosphate stimulates smooth muscle cell migration through Gαi- and PI3-kinase-dependent P38MAPK activation
AU - Fegley, Allison J.
AU - Tanski, William J.
AU - Roztocil, Elisa
AU - Davies, Mark G.
N1 - Funding Information:
This research was supported by grants for Mark G. Davies, M.D., Ph.D., from the American College of Surgeons Junior Faculty Award and from the Mentored Clinical Scientist Development Award, sponsored by the NIH-NHLBI/Lifeline Foundation (K08 HL 67746), and for William Tanski, M.D., from the NIH through a National Research Service Award (NRSA grant #1 F32 HL69598-01).
PY - 2003/7
Y1 - 2003/7
N2 - Background. Sphingosine-1-phosphate (S-1-P) is an extracellular mediator released in response to vessel injury. S-1-P binds to G-protein-coupled receptors, which can be Gαi-, Gαq-, or G 12/13-linked. This study examines the role of p38 mitogen-activated protein kinase (p38MAPK) in vascular smooth muscle cell migration after stimulation with S-1-P, and pathways leading to p38MAPK activation. S-1-P has previously been shown to stimulate migration of vascular smooth muscle cells (VSMCs) in vitro through ERK1/2 and Gi. We hypothesized that S-1-P-induced VSMC migration is also dependent on p38 MAPK activation through a Gi-coupled extracellular receptor and phosphoinositide 3-kinase (PI3-K). Methods. VSMCs were cultured in vitro. A linear wound assay was performed in the presence of S-1-P and inhibitors of p38MAPK (SB203580) or epidermal growth factor (EGF) receptor kinase (AG1478). Chemotaxis stimulated by S-1-P was also assayed in a modified Boyden chamber with and without SB203580 pretreatment. Western blotting was performed to examine p38MAPK activation in response to S-1-P with and without SB203580, AG1478, or inhibitors of Gi (pertussis toxin), PI3-K (Wortmannin and LY294002), or MEK1 (PD98059). Western blotting and immunoprecipitation for targets of p38MAPK (MAPKAP kinase-2) and PI3-K (Akt) were also performed. Results. S-1-P stimulated migration of VSMCs in both wound and Boyden transwell assays. This migration was inhibited by SB203580 to the level of control, whereas AG478 had no effect. S-1-P stimulated activation of p38MAPK that peaked at 10 min, as well as activation of MAPKAP kinase-2. Activation of p38MAPK was significantly inhibited by SB203580, pertussis toxin, Wortmannin, and LY294002, but not by PD98059 or AG1478; MAPKAP kinase-2 activation was inhibited by SB203580. Akt was activated by S-1-P at 3 to 5 min; this response was inhibited by Wortmannin and LY294002, but not by SB203580 or pertussis toxin. Conclusions. S-1-P induced VSMC migration through a Gi-linked and a PI3-K coupled, p38MAPK- dependent process. PI3-K appears to function upstream of p38MAPK, but was not Gi-dependent. S-1-P-stimulated activation of p38MAPK does not signal via transactivation of the EGF receptor. Understanding signal transduction will allow targeted molecular interventions to treat the response of a vessel to injury.
AB - Background. Sphingosine-1-phosphate (S-1-P) is an extracellular mediator released in response to vessel injury. S-1-P binds to G-protein-coupled receptors, which can be Gαi-, Gαq-, or G 12/13-linked. This study examines the role of p38 mitogen-activated protein kinase (p38MAPK) in vascular smooth muscle cell migration after stimulation with S-1-P, and pathways leading to p38MAPK activation. S-1-P has previously been shown to stimulate migration of vascular smooth muscle cells (VSMCs) in vitro through ERK1/2 and Gi. We hypothesized that S-1-P-induced VSMC migration is also dependent on p38 MAPK activation through a Gi-coupled extracellular receptor and phosphoinositide 3-kinase (PI3-K). Methods. VSMCs were cultured in vitro. A linear wound assay was performed in the presence of S-1-P and inhibitors of p38MAPK (SB203580) or epidermal growth factor (EGF) receptor kinase (AG1478). Chemotaxis stimulated by S-1-P was also assayed in a modified Boyden chamber with and without SB203580 pretreatment. Western blotting was performed to examine p38MAPK activation in response to S-1-P with and without SB203580, AG1478, or inhibitors of Gi (pertussis toxin), PI3-K (Wortmannin and LY294002), or MEK1 (PD98059). Western blotting and immunoprecipitation for targets of p38MAPK (MAPKAP kinase-2) and PI3-K (Akt) were also performed. Results. S-1-P stimulated migration of VSMCs in both wound and Boyden transwell assays. This migration was inhibited by SB203580 to the level of control, whereas AG478 had no effect. S-1-P stimulated activation of p38MAPK that peaked at 10 min, as well as activation of MAPKAP kinase-2. Activation of p38MAPK was significantly inhibited by SB203580, pertussis toxin, Wortmannin, and LY294002, but not by PD98059 or AG1478; MAPKAP kinase-2 activation was inhibited by SB203580. Akt was activated by S-1-P at 3 to 5 min; this response was inhibited by Wortmannin and LY294002, but not by SB203580 or pertussis toxin. Conclusions. S-1-P induced VSMC migration through a Gi-linked and a PI3-K coupled, p38MAPK- dependent process. PI3-K appears to function upstream of p38MAPK, but was not Gi-dependent. S-1-P-stimulated activation of p38MAPK does not signal via transactivation of the EGF receptor. Understanding signal transduction will allow targeted molecular interventions to treat the response of a vessel to injury.
KW - G-protein signaling
KW - Migration
KW - P38 MAP kinase
KW - PI3-kinase
KW - Signal transduction
KW - Smooth muscle cells
KW - Sphingosine-1-phosphate
UR - http://www.scopus.com/inward/record.url?scp=0042235069&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042235069&partnerID=8YFLogxK
U2 - 10.1016/S0022-4804(03)00120-3
DO - 10.1016/S0022-4804(03)00120-3
M3 - Article
C2 - 12943808
AN - SCOPUS:0042235069
SN - 0022-4804
VL - 113
SP - 32
EP - 41
JO - Journal of Surgical Research
JF - Journal of Surgical Research
IS - 1
ER -